2025 Press Releases 2025 2024 2023 2022 2021 Portfolio Companies New Leaf Portfolio Companies CuraSen Therapeutics Announces First Subject Treated with CuraAX (CST-3056) in a Phase 1 Clinical TrialFebruary 20, 2025 Kyruus Health and aha! Announce Partnership to Enhance Patient Access and EngagementFebruary 13, 2025 Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical TrialFebruary 11, 2025 Kyruus Health Achieves Record Growth as Searches for Care Surpass 1 BillionFebruary 5, 2025 Qlaris Bio Announces Positive Topline Data From Two Phase II Trials Of QLS-111 In Patients With Primary Open Angle Glaucoma And Ocular HypertensionFebruary 5, 2025 Bluesight Expands Compliance Capabilities and Strengthens Platform through Acquisition of ProtenusJanuary 9, 2025 Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)January 6, 2025
